5 day old neonate presented with vaginal bleeding. There were several pads with blood. She was a term baby and neonatal examination was documented as normal. She is clinically well. What is the most appropriate management? A. Admit for further observation. B. Perform coagulation studies. C. Do a Full blood count. D. Reassure and send home. E. Repeat IM Vit.K dose.
Reading File
Finding Sources
Searching the Web
neonatal vaginal bleeding physiological withdrawal bleeding management reassure
Answer: D. Reassure and send home
Why this is correct
This is a textbook case of neonatal (estrogen) withdrawal bleeding, also called "neonatal pseudomenstruation" or "false menses." It is a normal physiological phenomenon.
Mechanism:
- During pregnancy, the fetal endometrium is stimulated by high circulating maternal estrogens crossing the placenta.
- After birth, maternal estrogen levels drop abruptly.
- This estrogen withdrawal triggers endometrial shedding - producing small amounts of vaginal blood, typically on days 3-5 of life.
Key features that confirm this is physiological:
- Female neonate, term gestation
- Presents at day 5 (classic timing: days 3-7)
- Clinically well
- Normal neonatal examination
- No other bleeding sites (no evidence of coagulopathy)
Since the baby is clinically well, term, and the bleeding fits this classic pattern, no investigation or treatment is required. Parents simply need reassurance and explanation. As confirmed by AAP guidelines: "This neonatal withdrawal bleeding is a normal phenomenon with no treatment necessary, except reassurance and anticipatory guidance."
Why the other options are wrong
| Option | Why incorrect |
|---|---|
| A. Admit for observation | Unnecessary - the baby is well and this is a benign self-limiting condition |
| B. Coagulation studies | Only indicated if there are signs of haemorrhagic disease (bleeding from multiple sites, sick baby) - not warranted here |
| C. Full blood count | No clinical indication; she is well and not anaemic from this trivial blood loss |
| E. Repeat IM Vitamin K | Vitamin K deficiency bleeding (haemorrhagic disease of the newborn) would present with bleeding from multiple sites, umbilicus, or post-circumcision, typically in babies who did NOT receive prophylactic Vit K. This clinical picture does not fit VKDB |
When to worry (red flags that would change management)
- Bleeding from multiple sites (mouth, umbilicus, injection sites) - think VKDB - then give Vit K and check coagulation
- Sick or unwell neonate - investigate fully
- Vaginal bleeding beyond the first 2 weeks, or in a non-neonatal female - warrants urgent gynaecological evaluation to rule out tumour, trauma, or precocious puberty
The answer is D.
5 days old term baby with birth weight of 2.8kg, presented with vomiting, sneezing, jitteriness, lethargy and 12% weight loss. FBC, serum Calcium, Magnesium were normal. What is the next line of management. A. Oral morphine B. Top up breast feeding C. Anti reflux medications D. Reassure and discharge. E. IV fluids
Finding Sources
Searching the Web
neonatal abstinence syndrome NAS management oral morphine treatment guidelines
Reading File
Answer: A. Oral Morphine
Diagnosis: Neonatal Abstinence Syndrome (NAS) / Neonatal Opioid Withdrawal Syndrome (NOWS)
This baby's presentation is classic for NAS due to in-utero opioid exposure (maternal opioid use - heroin, methadone, buprenorphine, or prescribed opioids):
| Feature in this case | NAS significance |
|---|---|
| Vomiting | GI disturbance |
| Sneezing | Autonomic/respiratory sign |
| Jitteriness | CNS hyperexcitability / tremulousness |
| Lethargy | Neurological involvement |
| 12% weight loss | Poor feeding, vomiting - significant |
| Normal FBC, Ca²⁺, Mg²⁺ | Excludes metabolic/haematological causes |
| Day 5 onset | Classic timing (opioid withdrawal: 24-72h; methadone: up to day 7-10) |
The normal calcium and magnesium effectively rule out hypocalcaemia and hypomagnesaemia as causes of jitteriness/seizures.
Why Oral Morphine (A) is correct
When NAS is confirmed and supportive measures alone are insufficient (as indicated here by 12% weight loss, vomiting, and multisystem involvement), pharmacological treatment is indicated. Oral morphine is the first-line pharmacological agent for opioid-related NAS per established guidelines:
- It directly treats the underlying opioid withdrawal by substituting opioid receptor stimulation
- Doses are titrated to the Finnegan Neonatal Abstinence Scoring Tool (FNAST) score
- Typical starting dose: 0.05-0.1 mg/kg/dose every 3-4 hours, titrated upward based on scores
- Per Brigham & Women's NAS guidelines: oral morphine is the anchor of opioid-withdrawal NAS treatment, often with adjuncts (clonidine or phenobarbital)
As confirmed in Rosen's Emergency Medicine: "NAS/NOWS is a constellation of CNS disturbances, metabolic/respiratory abnormalities, and GI disturbances... Treatment of NOWS is supportive" - but when the syndrome is moderate-severe, pharmacological support with oral morphine is required.
Why the other options are wrong
| Option | Why incorrect |
|---|---|
| B. Top up breastfeeding | Breastfeeding IS encouraged as a supportive measure in NAS (small amounts of morphine in breast milk actually help), but with 12% weight loss and active vomiting, breastfeeding supplementation alone is insufficient - pharmacological treatment is required |
| C. Anti-reflux medications | Vomiting here is due to opioid withdrawal, not GER/GERD - anti-reflux agents won't address the underlying cause |
| D. Reassure and discharge | This baby has significant weight loss (12% - threshold for concern is >10%), multisystem NAS symptoms, and needs monitoring and treatment - discharging is unsafe |
| E. IV fluids | May be a supportive adjunct if severely dehydrated, but IV fluids do not treat the underlying opioid withdrawal. They would be secondary, not the primary next step |
Key Clinical Pearl
The Finnegan scoring system guides treatment thresholds:
- Score ≥8 on two consecutive assessments (or ≥12 once): initiate pharmacotherapy
- This baby's 12% weight loss + multisystem features strongly suggest a high Finnegan score
Non-pharmacological (supportive) measures should always accompany drug treatment: swaddling, low-stimulation environment, rooming-in with mother, and breastfeeding (if mother is on stable opioid replacement therapy and not using illicit drugs).
The answer is A - Oral Morphine.
This is a shared conversation. Sign in to Orris to start your own chat.